<p class="CxSpFirst" style="margin-bottom: 32px; margin-left: 96px;"><span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">08:30 . Welkom<br /> 08:55 . Introductie&nbsp;| Olivier Vandenberg, LHUB-ULB</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif"><b style="box-sizing:border-box; font-weight:700"><span style="box-sizing:border-box"><span style="color:#113671">Sessie 1: Oncologie en laboratoriumgeneeskunde</span></span></b></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif"><b style="box-sizing:border-box; font-weight:700"><span style="box-sizing:border-box"><span style="color:#113671">Chairman:&nbsp; Frédéric Cotton, LHUB-ULB</span></span></b></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">09:00· WHO perspective on the contribution of academic clinical laboratories in cancer research<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; </span></span></span></span></span></span><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">Prof. Zisis Kozlakidis, MD, PhD, Head, Laboratory Services and Biobanking at International<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;Agency for Research on Cancer (IARC), WHO, Lyon, France</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">09:45. The Role of Laboratory Medicine in Precision oncology: future or illusion?<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</span></span></span></span></span></span><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">Marc Van Den Bulcke, Head Cancer Centre, Sciensano, Brussels, Belgium</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">10:15&nbsp;<b style="box-sizing:border-box; font-weight:700">.</b>&nbsp;Weefsel- en circulerende biomarkers in de oncologie: vooruitgang, beperkingen<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;en hoop van de clinicus<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</span></span></span></span></span></span><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">Yassine Lalami, Kliniek voor medische oncologie, Jules Bordet Instituut</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif"><b style="box-sizing:border-box; font-weight:700"><i style="box-sizing:border-box">Coffee break (10:45-11:15)</i></b></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">11:15 . Paraeoplastische syndromen<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</span></span></span></span></span></span><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">Julie Smets, Dienst Immunologie, LHUB-ULB</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">11:45&nbsp;<b style="box-sizing:border-box; font-weight:700">. </b>Flowcytometrie en verdachte proliferatie in de hematologie<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</span></span></span></span></span></span><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">Valéry Daubie &amp; Hussein Farhat, Dienst Hematologie, LHUB-ULB</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif"><b style="box-sizing:border-box; font-weight:700"><i style="box-sizing:border-box">Lunch break &amp; Sponsors exhibition (12:15-13:30)</i></b></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif"><b style="box-sizing:border-box; font-weight:700"><span lang="FR-BE" style="box-sizing:border-box" xml:lang="FR-BE"><span style="color:#113671">Sessie 2: Unieke kenmerken van het universitaire laboratorium</span></span></b></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif"><b style="box-sizing:border-box; font-weight:700"><span lang="FR-BE" style="box-sizing:border-box" xml:lang="FR-BE"><span style="color:#113671">Chairman:&nbsp;&nbsp;</span></span></b><b style="box-sizing:border-box; font-weight:700"><span lang="FR-BE" style="box-sizing:border-box" xml:lang="FR-BE"><span style="color:#002060">Olivier Vandenberg, LHUB-ULB</span></span></b></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">13:30 . Bijdrage van de cluster Optilab Montréal CHUM aan de activiteiten van de Universiteit<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;van Montréal<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Christian Lavallée, MD, MSc, FRCPC, Medisch Directeur, OPTILAB Montréal CHUM Cluster,<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Universiteit van Montréal</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt"><span style="box-sizing:border-box"><span style="box-sizing:border-box"><span style="line-height:normal"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">14:15&nbsp;<b style="box-sizing:border-box; font-weight:700">.&nbsp;</b>Bijdrage van LHUB-ULB aan de fundamentele missies van de universiteit.&nbsp; Stand van zaken<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;en verwachtingen van de&nbsp;Pôle Santé van de Université libre de Bruxelles<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Olivier Vandenberg, Eenheid Onderzoek en Technologische Innovatie (EOTI), LHUB-ULB</span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><font face="Calibri, sans-serif"><font style="box-sizing:border-box"><span style="font-size:14.6667px"><span style="box-sizing:border-box">14:45 . LHUB-ULB in het hart van een Europees netwerk voor zeldzame hematologische ziekten:<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;stoppen of doorgaan?<br /> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Béatrice Gulbis, LHUB-ULB</span></span></font></font></span></span></span></span></span></span></span></span></span></span></span><br /> <br /> <span style="font-size:16px"><span style="box-sizing:border-box"><span style="color:#2f323a"><span style="font-family:fira-sans, Helvetica, Arial, sans-serif"><span style="font-style:normal"><span style="font-variant-ligatures:normal"><span style="font-weight:400"><span style="white-space:normal"><span style="text-decoration-thickness:initial"><span style="text-decoration-style:initial"><span style="text-decoration-color:initial"><span style="font-size:11pt; text-indent:-69.75pt"><span style="box-sizing:border-box"><span style="font-family:Calibri, sans-serif">15:30 . Conclusies&nbsp;| Anne Demulder, LHUB-ULB</span></span></span></span></span></span></span></span></span></span></span></span></span></span></p> , Symposium - LHUB-ULB annual, Symposium - LHUB-ULB annual
…           Prof. Zisis Kozlakidis, MD, PhD, Head, Laboratory Services and Biobanking at International             Agency …